In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...

Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...

Smoke from wildfires — like the ones in Los Angeles — can have health consequences. Here's what experts expect.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

While wildfires can cause immediate destruction to homes and towns, a few weeks of smoke exposure should not have long-term ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).